{"id":"W4415547445","doi":"10.1016/j.cjco.2025.10.007","title":"Outcomes, Safety and Tolerability of Sacubitril-Valsartan over 3 years of Follow-up in Canadian Practice: Insights from the PARTHENON Registry","year":2025,"lang":"en","type":"article","venue":"CJC Open","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Women's College Hospital; University of Calgary; Libin Cardiovascular Institute of Alberta; Women and Children’s Health Research Institute; Université de Montréal; Montreal Heart Institute; Novartis (Canada)","funders":"Novartis Pharmaceuticals Canada; Novo Nordisk; Cytokinetics; Sanofi; AstraZeneca; Alnylam Pharmaceuticals; American Regent; Servier; Pfizer; Amgen","keywords":"Tolerability; Context (archaeology); Clinical trial; MEDLINE","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003644519,0.00008526582,0.0005165988,0.00005510026,0.00003446149,0.00001831064,0.0001493068,0.00005933578,0.00009252478],"category_scores_gemma":[0.0004213131,0.00005946708,0.0000403019,0.0001754227,0.00006377596,0.000106891,0.0001210197,0.00009947829,0.000003327395],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001158372,"about_ca_system_score_gemma":0.0003828542,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.4635499,"about_ca_topic_score_gemma":0.418524,"domain_scores_codex":[0.9991527,0.00009962093,0.000302711,0.0001888461,0.0001217019,0.0001344469],"domain_scores_gemma":[0.9989775,0.0003198335,0.00008440737,0.0004930734,0.00004142229,0.00008370607],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007852793,0.000211562,0.9706309,0.00006264885,0.0003719981,0.00006431126,0.001845603,0.000001711863,0.0001103962,0.005859641,0.01083232,0.009223643],"study_design_scores_gemma":[0.002197449,0.00004095829,0.6850703,0.0001123311,0.0001305948,4.319136e-7,0.0004302636,0.00001024143,0.0000793276,0.0003144118,0.3115721,0.00004156495],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9582564,0.0005659597,0.000004779106,0.01528135,0.000127418,0.001315474,0.00004028014,0.00000513697,0.02440324],"genre_scores_gemma":[0.9960628,0.00009130821,0.0003181871,0.001052204,0.000009617669,0.00001462015,0.00003017218,0.000005424453,0.002415738],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3007398,"threshold_uncertainty_score":0.5920864,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01705918920882179,"score_gpt":0.3189499743129275,"score_spread":0.3018907851041058,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}